Use of convalescent plasma in pregnant women with early stage COVID-19 infection in a tertiary care hospital in Dubai, February to March 2021: a case series study

• Váldodahkkit: Heba Adan (Dahkki), Deemah Harb (Dahkki), Komal Hazari (Dahkki), Widad Abdelkareem (Dahkki), Fareeda Nikhat Khan (Dahkki), Maryam Zouaoui (Dahkki), May Raouf (Dahkki), Doaa Elsawy (Dahkki), Aida Joseph Azar (Dahkki), Amar Hassan Khamis (Dahkki), Abeer Ammar (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: BMC, 2022-09-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Abstract Background The use of COVID-19 convalescent plasma (CCP) for the treatment of SARS-CoV-2 infection in pregnancy is intriguing in view of its safety profile in pregnancy and historical precedence of the use of plasma for other viral illnesses. This study aimed to evaluate the use of CCP in p...